The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Drug therapy for the management of cancer-related fatigue
Open accessAbstract
BACKGROUND: This is an updated version of the original Cochrane review published in issue 1 2008 (Minton 2008). Cancer-related fatigue (CRF) is common, under-recognised and difficult to treat. There have been studies looking at drug interventions to improve CRF but results have been conflicting depending on the population studied and outcome measures used. No previous reviews of this topic have been exhaustive or have synthesised all available data. OBJECTIVES: To assess the efficacy of drugs for the management of CRF. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (from Issue 2 2007) MEDLINE and EMBASE from January 2007 to October 2009 and a selection of cancer journals. We searched references of identified articles and contacted authors to obtain unreported data. SELECTION CRITERIA: Studies were included in the review if they 1) assessed drug therapy for the management of CRF compared to placebo, usual care or a non-pharmacological intervention in 2) randomised controlled trials (RCT) of 3) adult patients with a clinical diagnosis of cancer. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trial quality and extracted data. Meta-analyses were performed on different drug classes using continuous variable data. MAIN RESULTS: Fifty studies met the inclusion criteria. Six additional studies were identified since the original review. Only 31 of these studies involving 7104 participants were judged to have used a sufficiently robust measure of fatigue and thus were deemed suitable for detailed analysis. The drugs were still analysed by class (psychostimulants; haemopoietic growth factors; antidepressants and progestational steroids). Methylphenidate showed a small but significant improvement in fatigue over placebo (Z = 2.83; P = 0.005). Since the publication of the original review increased safety concerns have been raised regarding erythropoietin and this cannot now be recommended in practice.There was a very high degree of statistical and clinical heterogeneity in the trials and the reasons for this are discussed. AUTHORS' CONCLUSIONS: There is increasing evidence that psychostimulant trials provide evidence for improvement in CRF at a clinically meaningful level. There is still a requirement for a large scale RCT of methylphenidate to confirm the preliminary results from this review. There is new safety data which indicates that the haemopoietic growth factors are associated with increased adverse outcomes. These drugs can no longer be recommended in the treatment of CRF. Readers of the first review should re-read the document in full.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Meta-Analysis in Clinical Research
L'ABBÉ, K. A., DETSKY, A. S., & O'ROURKE, K. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-224 · Cited by 1,267
Exercise for the management of cancer-related fatigue in adults
Cramp, F., & Byron-Daniel, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006145.pub3 · Cited by 1,096
Krupp, L. B., Alvarez, L. A., LaRocca, N. G., & Scheinberg, L. C. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520280085020 · Cited by 997
Littlewood, T. J., Bajetta, E., Nortier, J. W. R., Vercammen, E., Rapoport, B., & for the Epoetin Alfa Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2865 · Cited by 974
Wilkinson, E. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00737-4 · Cited by 951
Cella, D., Eton, D. T., Lai, J.-S., Peterman, A. H., & Merkel, D. E. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00529-8 · Cited by 808
Capuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797
Demetri, G. D., Kris, M., Wade, J., Degos, L., & Cella, D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3412 · Cited by 751
Glaspy, J., Bukowski, R., Steinberg, D., Taylor, C., Tchekmedyian, S., & Vadhan-Raj, S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1218 · Cited by 693
Leyland-Jones, B., Semiglazov, V., Pawlicki, M., Pienkowski, T., Tjulandin, S., Manikhas, G., Makhson, A., Roth, A., Dodwell, D., Baselga, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.150 · Cited by 668
Cella, D., Davis, K., Breitbart, W., Curt, G., & Coalition, F. T. F. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3385 · Cited by 652
Bohlius, J., Schmidlin, K., Brillant, C., Schwarzer, G., Trelle, S., Seidenfeld, J., Zwahlen, M., Clarke, M., Weingart, O., Kluge, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60502-x · Cited by 597
Vansteenkiste, J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1211 · Cited by 477
Stone, P., Richardson, A., Ream, E., Smith, A. G., Kerr, D. J., & Kearney, N. (2000) · Annals of Oncology · doi:10.1023/a:1008318932641 · Cited by 438
Wright, J. R., Ung, Y. C., Julian, J. A., Pritchard, K. I., Whelan, T. J., Smith, C., Szechtman, B., Roa, W., Mulroy, L., Rudinskas, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1514 · Cited by 428
Exercise for the management of cancer-related fatigue in adults
Cramp, F., & Daniel, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006145.pub2 · Cited by 385
Bruera, E. D., Roca, E. L., Cedaro, L., Carraro, S., & Chacon, R. (1985) · PubMed · Cited by 348
Morrow, G. R., Hickok, J. T., Roscoe, J. A., Raubertas, R. F., Andrews, P. L. R., Flynn, P. J., Hynes, H. E., Banerjee, T. K., Kirshner, J. J., & King, D. K. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.070 · Cited by 324
Österborg, A., Brandberg, Y., Molostova, V., Iosava, G., Abdulkadyrov, K., Hedenus, M., & Messinger, D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.131 · Cited by 310
Bruera, E., Valero, V., Driver, L., Shen, L., Willey, J., Zhang, T., & Palmer, J. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8506 · Cited by 289
Bruera, E., Strasser, F., Palmer, J. L., Willey, J., Calder, K., Amyotte, G., & Baracos, V. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.101 · Cited by 287
Fatigue and psychological distress in the working population
Bültmann, U., Kant, I., Kasl, S. V., Beurskens, A. J. H. M., & van den Brandt, P. A. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00228-8 · Cited by 283
Corticosteroid therapy of preterminal gastrointestinal cancer
Moertel, C. G., Schutt, A. J., Reitemeier, R. J., & Hahn, R. G. (1974) · Cancer · doi:10.1002/1097-0142(197406)33:6<1607::aid-cncr2820330620>3.0.co;2-v · Cited by 258
Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer
Breitbart, W., Bruera, E., Chochinov, H., & Lynch, M. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)00075-v · Cited by 246
Fatigue associated with cancer and its treatment
Morrow, G. R., Andrews, P. L., Hickok, J. T., Roscoe, J. A., & Matteson, S. (2002) · Supportive Care in Cancer · doi:10.1007/s005200100293 · Cited by 241
Pharmacological treatments for fatigue associated with palliative care
Mücke, M., Mochamat, M., Cuhls, H., Peuckmann-Post, V., Minton, O., Stone, P., & Radbruch, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006788.pub3 · Cited by 227
Self-citationBarton, D. L., Soori, G. S., Bauer, B. A., Sloan, J. A., Johnson, P. A., Figueras, C., Duane, S., Mattar, B., Liu, H., Atherton, P. J., et al. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-009-0642-2 · Cited by 215
Butler, J. M., Case, L. D., Atkins, J., Frizzell, B., Sanders, G., Griffin, P., Lesser, G., McMullen, K., McQuellon, R., Naughton, M., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.05.076 · Cited by 214
Witzig, T. E., Silberstein, P. T., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., Mailliard, J. A., Rowland, K. M., Alberts, S. R., Krook, J. E., Levitt, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.020 · Cited by 209
Management of Cancer-Related Fatigue
Morrow, G. R., Shelke, A. R., Roscoe, J. A., Hickok, J. T., & Mustian, K. (2005) · Cancer Investigation · doi:10.1081/cnv-200055960 · Cited by 205
Breitbart, W., Rosenfeld, B., Kaim, M., & Funesti-Esch, J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.411 · Cited by 203
Mar Fan, H. G., Clemons, M., Xu, W., Chemerynsky, I., Breunis, H., Braganza, S., & Tannock, I. F. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-007-0341-9 · Cited by 198
Roscoe, J. A., Morrow, G. R., Hickok, J. T., Mustian, K. M., Griggs, J. J., Matteson, S. E., Bushunow, P., Qazi, R., & Smith, B. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-2175-1 · Cited by 197
Lower, E. E., Fleishman, S., Cooper, A., Zeldis, J., Faleck, H., Yu, Z., & Manning, D. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.03.011 · Cited by 197
Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma
Dammacco, F., Castoldi, G., & Rödjer, S. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02715.x · Cited by 181
Monk, J. P., Phillips, G., Waite, R., Kuhn, J., Schaaf, L. J., Otterson, G. A., Guttridge, D., Rhoades, C., Shah, M., Criswell, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2838 · Cited by 179
Fisch, M. J., Loehrer, P. J., Kristeller, J., Passik, S., Jung, S.-H., Shen, J., Arquette, M. A., Brames, M. J., & Einhorn, L. H. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.025 · Cited by 176
Methylprednisolone as palliative therapy for female terminal cancer patients
Metz, C. A., Popiela, T., Lucchi, R., & Giongo, F. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90354-4 · Cited by 173
Diel, I. J., Body, J.-J., Lichinitser, M. R., Kreuser, E. D., Dornoff, W., Gorbunova, V. A., Budde, M., & Bergström, B. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.025 · Cited by 166
Metz, C. A., Robustelli Della Cuna, G., Pellegrini, A., & Piazzi, M. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90353-2 · Cited by 162
Agteresch, H. J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.4.321 · Cited by 154
Stockler, M. R., O’Connell, R. L., Nowak, A. K., Goldstein, D., Turner, J., Wilcken, N., Wyld, D., Abdi, E. A., Glasgow, A., Beale, P. J., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70148-1 · Cited by 152
Erythropoietin or Darbepoetin for patients with cancer
Bohlius, J., Wilson, J. S., Seidenfeld, J., Piper, M., Schwarzer, G., Sandercock, J., Trelle, S., Weingart, O., Bayliss, S. E., Brunskill, S. J., et al. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003407.pub4 · Cited by 149
Evidence-Based Treatment for Cancer-Related Fatigue
Mock, V. (2004) · JNCI Monographs · doi:10.1093/jncimonographs/lgh025 · Cited by 147
Kotasek, D., Steger, G. G., Faught, W., Underhill, C. R., Poulsen, E., Colowick, A. B., Rossi, G., & Mackey, J. A. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00456-8 · Cited by 139
Thatcher, N. J., Campos, E. S. D., Bell, D., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690369 · Cited by 129
Impact of epoetin β on quality of life in patients with malignant disease
and the Epoetin β QOL Working Group, Boogaerts, M. A., Coiffier, B., & Kainz, C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600801 · Cited by 119
O’Shaughnessy, J., Vukelja, S. J., Holmes, F. A., Savin, M. A., Jones, M., Royall, D. R., George, M. J., & Hoff, D. D. V. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.002 · Cited by 114
Donepezil for Cancer Fatigue: A Double-Blind, Randomized, Placebo-Controlled Trial
Bruera, E. D., Osta, B. E. E., Valero, V., Driver, L., Pei, B.-L., Shen, L. F., Poulter, V. A., & Palmer, J. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9231 · Cited by 114
Simons, J. P., Aaronson, N. K., Vansteenkiste, J., ten Velde, G. P. M., Muller, M. J., Drenth, B. M. H., Erdkamp, F., Cobben, E. G., Schoon, E. J., Smeets, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1077 · Cited by 113
A population-based incidence study of chronic fatigue
Lawrie, S. M., MANDERS, D. N., Geddes, J. R., & Pelosi, A. J. (1997) · Psychological Medicine · doi:10.1017/s0033291796004357 · Cited by 110
Curt, G. A. (2001) · BMJ · doi:10.1136/bmj.322.7302.1560 · Cited by 107
On the Road to New Drugs in Acute Myeloid Leukemia
Löwenberg, B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6462 · Cited by 101
Mantovani, G., Macciò, A., Madeddu, C., et al. (2008) · Nutrition · doi:10.1016/j.nut.2007.12.010 · Cited by 101
Bruera, E. D., Ernst, S., Hagen, N. A., Spachynski, K., Belzile, M., Hanson, J., Summers, N., Brown, B. A., Dulude, H., & Gallant, G. (1998) · PubMed · Cited by 99
Conno, F. D., Martini, C., Zecca, E., Balzarini, A., Venturino, P., Groff, L., & Caraceni, A. T. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00219-6 · Cited by 93
Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer
Abels, R. I., Larholt, K. M., Krantz, K. D., & Bryant, E. C. (1991) · Stem Cells · doi:10.1002/stem.5530090714 · Cited by 93
Glaspy, J. A., Jadeja, J., Justice, G. R., Fleishman, A. N., Rossi, G., & Colowick, A. B. (2003) · Cancer · doi:10.1002/cncr.11186 · Cited by 90
Epoetin alfa improves quality of life in patients with cancer
Jones, M., Schenkel, B., Just, J., & Fallowfield, L. J. (2004) · Cancer · doi:10.1002/cncr.20569 · Cited by 89
Preliminary Evaluation of a Clinical Syndrome Approach to Assessing Cancer-Related Fatigue
Sadler, I. J., Jacobsen, P. B., Booth‐Jones, M., Belanger, H. G., Weitzner, M. A., & Fields, K. K. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00388-3 · Cited by 89
Семиглазов, В. Ф., Stepula, V. V., Dudov, A., Schnitker, J., & Mengs, U. (2006) · PubMed · Cited by 89
Fatigue after breast cancer and in chronic fatigue syndrome
Servaes, P., Prins, J. B., Verhagen, S. C. A. H. H. V. M., & Bleijenberg, G. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00300-8 · Cited by 85
Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer.
Glimelius, B. L. G., Linné, T., Hoffman, K., Larsson, L., Svensson, J.-H., Näsman, P., Svensson, B., & Helmers, C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.434 · Cited by 82
Glaspy, J. A., Vadhan‐Raj, S., Patel, R., Bosserman, L. D., Hu, E. H.-L., Lloyd, R. E., Boccia, R. V., Tomita, D. K., & Rossi, G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8570 · Cited by 80
Courneya, K. S., Jones, L. W., Peddle‐McIntyre, C. J., Sellar, C. M., Reiman, T., Joy, A. A., Chua, N. S., Tkachuk, L., & Mackey, J. R. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0017 · Cited by 78
for the Aranesp® 990111 Study Group, Smith, R. E., Tchekmedyian, N. S., Chan, D., Meza, L., Northfelt, D., Patel, R., Austin, M., Colowick, A. B., Rossi, G., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600994 · Cited by 75
A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia
Downer, S. M., Joel, S., Allbright, A., Plant, H., Stubbs, L., Talbot, D., & Slevin, M. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.202 · Cited by 71
Auret, K. A., Schug, S. A., Bremner, A., & Bulsara, M. K. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2008.03.016 · Cited by 63
Miranda, V. D. C., Trufelli, D. C., Santos, J. P. M., Campos, M. P. D. O., Nobuo, M., Miranda, M. D. C., Schlinder, F., Riechelmann, R. P., & del Giglio, A. (2009) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2008.0324 · Cited by 61
Westman, G., Bergman, B., Albertsson, M., Kadar, L., Gustavsson, G., Thaning, L., Andersson, M. V., Straumits, A., Jeppsson, B. W., Lindén, C. J., et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00398-0 · Cited by 61
The measurement, causes and effective management of cancer-related fatigue
Stone, P. C. (2002) · International Journal of Palliative Nursing · doi:10.12968/ijpn.2002.8.3.10248 · Cited by 61
Self-citationJ-E. Johansson, P. W. (2001) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655901750425864 · Cited by 59
Bamias, A., Aravantinos, G., Kalofonos, H. P., Timotheadou, N., Siafaka, V., Vlahou, I., Janinis, D., Pectasides, D., Pavlidis, N. A., & Fountzilas, G. (2003) · Oncology · doi:10.1159/000067766 · Cited by 51
Inoue, A., Yamada, Y., Matsumura, Y., Shimada, Y., Muro, K., Gotoh, M., Hamaguchi, T., Mizuno, T., & Shirao, K. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-003-0488-y · Cited by 50
for the EPO-INT-45 Study Group, Wilkinson, P. M., Antonopoulos, M., Lahousen, M., Lind, M., & Kosmidis, P. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603004 · Cited by 49
Recombinant Human Erythropoietin (rHuEPO) for the Treatment of the Anemia of Cancer
Abels, R. I., Larholt, K. M., Krantz, K. D., & Bryant, E. C. (1996) · The Oncologist · doi:10.1634/theoncologist.1-3-140 · Cited by 44
Savonije, J. H., van Groeningen, C. J., van Bochove, A., Honkoop, A. H., van Felius, C. L., Wormhoudt, L. W., & Giaccone, G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.024 · Cited by 42
Fêde, Â., Bensi, C. G., Trufelli, D. C., Campos, M. P. D. O., Pecoroni, P. G., Ranzatti, R. P., Kaliks, R. A., & del Giglio, A. (2007) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31804b40d9 · Cited by 40
Iconomou, G., Koutras, A. K., Rigopoulos, A., Vagenakis, A. G., & Kalofonos, H. P. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00070-8 · Cited by 40
Andrews, P. L. R., Morrow, G. R., Hickok, J. T., Roscoe, J. A., & Stone, P. (2004) · Oxford University Press eBooks · doi:10.1093/oso/9780192630940.003.0003 · Cited by 35
Self-citationCharu, V., Belani, C. P., Gill, A. N., Bhatt, M., Tomita, D. K., Rossi, G., & Ben-Jacob, A. (2007) · The Oncologist · doi:10.1634/theoncologist.12-6-727 · Cited by 33
Tsuboi, M., Ezaki, K., Tobinai, K., Ohashi, Y., & Saijo, N. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn151 · Cited by 29
Drugs for the treatment of fatigue in palliative care
Radbruch, L., Elsner, F., Krumm, N., Peuckmann‐Post, V., & Trottenberg, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006788 · Cited by 27
Exercise for treatment of cancer related fatigue
Cramp, F. L., Prue, G., & Gracey, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006145 · Cited by 18
Glossmann, J.-P., Engert, A., Wassmer, G., Flechtner, H., Ko, Y. H., Rudolph, C., Metzner, B., Dörken, B., Wiedenmann, S., Diehl, V., et al. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0695-0 · Cited by 17
Assessing fatigue in patients with COPD.
Trendall, J. (2001) · PubMed · Cited by 14
Heras, P., Kritikos, K., Hatzopoulos, A., & Mitsibounas, D. (2008) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2007.00892.x · Cited by 7
Cited by
Exercise for the management of cancer-related fatigue in adults
Cramp, F., & Byron-Daniel, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006145.pub3 · Cited by 1,096
Cancer-Related Fatigue, Version 2.2015
Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., Cleeland, C., Dotan, E., Eisenberger, M. A., Escalante, C. P., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0122 · Cited by 949
Brahmer, J. R., Abu-Sbeih, H., Ascierto, P. A., Brufsky, J., Cappelli, L. C., Cortazar, F. B., Gerber, D. E., Hamad, L., Hansen, E., Johnson, D. B., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002435 · Cited by 917
Cancer‐related fatigue: Evolving concepts in evaluation and treatment
Stasi, R., Abriani, L., Beccaglia, P., Terzoli, E., & Amadori, S. (2003) · Cancer · doi:10.1002/cncr.11742 · Cited by 712
Bower, J. E., Bak, K., Berger, A., Breitbart, W., Escalante, C. P., Ganz, P. A., Schnipper, H. H., Lacchetti, C., Ligibel, J. A., Lyman, G. H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.4495 · Cited by 671
Metadata
- Authors
- Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-07-07
- Volume
- 2013
- Issue
- 12
- Pages
- CD006704-CD006704
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1952315861
- Cited by
- 283
- References
- 93
- FWCI
- 14.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.